Paper28294295
Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
Giuliano AE and 8 others. CA Cancer J Clin, 2017. Cited by 764 papers, by iCite.
Cite this record
ConductScience Library. Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. Papers, record 28294295. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28294295
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Neoplasm Staging | Major topic |
| Biomarkers, Tumor | |
| Female | |
| Humans | |
| Lymphatic Metastasis | |
| Neoplasm Metastasis | |
| Practice Guidelines as Topic | |
| Prognosis | |
| United States |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P30CA016672 | NIH |
Source NIH RePORTER
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT07003009 | Immun Checkpoint Washout in Patients With Invasive Ductal Breast Cancer | Results |
Source ClinicalTrials.gov
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 28689371 | Erratum: Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. | https://conductscience.org/library/papers/28689371 |
Source PubMed
Cited by515
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 764 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42955120 | Characterizing potential subgroups and predictive factors of cancer-related fatigue among breast cancer patients through latent profile analysis and machine learning algorithms. | Support Care Cancer | 2026 | https://conductscience.org/library/papers/42955120 | PubMed |
| 42941313 | Receptor Status Changes, HER2-Low Discordance, and TNBC Transformation in Metastatic Breast Cancer: Prognostic Significance and Impact on Survival Outcomes. | J Clin Med | 2026 | https://conductscience.org/library/papers/42941313 | PubMed |
| 42930205 | Association Between the Number of Invasive Tumor Foci and Axillary Nodal Burden in Multifocal and Multicentric Breast Cancer. | Curr Oncol | 2026 | https://conductscience.org/library/papers/42930205 | PubMed |
| 42920161 | Advancing women's health in Egypt: an economic evaluation of the presidential initiative for nationwide breast cancer early detection and treatment. | Arch Public Health | 2026 | https://conductscience.org/library/papers/42920161 | PubMed |
| 42890536 | New insights into tumor size in colorectal cancer: smaller size, higher risk? | Front Oncol | 2026 | https://conductscience.org/library/papers/42890536 | PubMed |
| 42811741 | Optimizing the ER Cutoff in HER2-Positive Breast Cancer: ER ≥ 50% Predicts Low pCR Rates and Resistance to Antibody-Drug Conjugates in the Neoadjuvant Setting. | Cancer Med | 2026 | https://conductscience.org/library/papers/42811741 | PubMed |
| 42742922 | Distinct risk profiles of heart failure and non-heart failure major adverse cardiovascular events among patients with early breast cancer: a competing-risk analysis. | Int J Clin Oncol | 2026 | https://conductscience.org/library/papers/42742922 | PubMed |
| 42731006 | [Sentinel node biopsy and lymphatic mapping from a nuclear medicine perspective: principles, methods and experiences in Szeged]. | Magy Onkol | 2026 | https://conductscience.org/library/papers/42731006 | PubMed |
| 42598618 | Clear cell Paget disease with underlying malignancy: A case report and review of literature. | Radiol Case Rep | 2026 | https://conductscience.org/library/papers/42598618 | PubMed |
| 42578630 | Prognostic significance of isolated tumor cells and nodal tumor burden in endometrial cancer: a population-based cohort study. | Acta Oncol | 2026 | https://conductscience.org/library/papers/42578630 | PubMed |
| 42540580 | The role of body mass index and tumor necrosis factor α in breast cancer development: a case-control study. | Arch Med Sci | 2026 | https://conductscience.org/library/papers/42540580 | PubMed |
| 42516134 | Risk factors for radiation pneumonitis following adjuvant radiotherapy for breast cancer: a retrospective cohort study. | Front Oncol | 2026 | https://conductscience.org/library/papers/42516134 | PubMed |
| 42513228 | Breast Cancer: Epidemiology, Molecular Classification, Diagnostics and Evolving Treatment Paradigms. | Molecules | 2026 | https://conductscience.org/library/papers/42513228 | PubMed |
| 42512804 | HER2-Low Versus HER2-Zero Breast Cancer in the Neoadjuvant Setting: Pathological Complete Response and Exploratory Survival Outcomes in a Single-Center Cohort. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/42512804 | PubMed |
| 42403201 | BI-RADS v2025 for breast ultrasound: key updates and Asian perspectives. | Ultrasonography | 2026 | https://conductscience.org/library/papers/42403201 | PubMed |
| 42399903 | Plexin A2 regulated the metastasis in breast cancer through MCM7. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42399903 | PubMed |
| 42393102 | Stage-related transcriptional changes in HR-positive/HER2-negative breast cancer. | NPJ Breast Cancer | 2026 | https://conductscience.org/library/papers/42393102 | PubMed |
| 42323696 | Impact of somatic PIK3CA mutations on clinical outcomes in HER2-positive breast cancer. | Breast Cancer Res | 2026 | https://conductscience.org/library/papers/42323696 | PubMed |
| 42322704 | Thermal ablation for early-stage breast cancer: cryoablation, microwave ablation, radiofrequency ablation, high-intensity focused ultrasound ablation, and laser ablation - a systematic review. | Breast | 2026 | https://conductscience.org/library/papers/42322704 | PubMed |
| 42319488 | Automatic metabolic breast cancer staging using [¹⁸F]FDG PET/CT: comparison with nuclear medicine physician-based and clinical staging. | Eur J Nucl Med Mol Imaging | 2026 | https://conductscience.org/library/papers/42319488 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| NR4A1 | 3164 | PubTator's text mining | https://conductscience.org/library/genes/3164 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28294295
GET https://conductscience.org/api/papers/v1/28294295/cited_by?page=2